What We’re Reading: WHO's AI Warning; SC and Abortion; Court Blocks Texas RulingMay 16th 2023
WHO urges caution regarding artificial intelligence (AI) bias; South Carolina ban would restrict abortion at 6 weeks; appeals court pauses ruling barring free preventative health services.
Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use
Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.
Nine From ViVE: Takeaways From the Digital Health ConferenceApril 9th 2023
This 4-day event drew thousands of health care leaders to Nashville, Tennessee; in this column, Ron Southwick, editor of Chief Healthcare Executive, shares his thoughts from conversations and panels in Music City.
FDA Outlines Next Steps to Weave Digital Health Data Into Clinical TrialsMarch 24th 2023
Digital health data can facilitate the participation of underrepresented and diverse patient populations in clinical trials, but first the FDA must build its capability to evaluate such information in its regulatory processes for new drug development.
Chatbot Systems Using AI May Feasibly Provide Access to Information on Infectious DiseasesMarch 19th 2023
A recent study found that chatbot systems that used artificial intelligence (AI) could be valuable in providing access to current, accurate, and complete information about infectious diseases and vaccines against them.
Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of CareMarch 18th 2023
Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to care in the first place.
Dr Sashi Naidu: Partnering With Molecular Diagnostic Labs Facilitates Advanced Cancer CareMarch 6th 2023
Carolina Blood and Cancer Care Associates’ No One Left Alone initiative works to dismantle cancer health disparities and increase health care equity among its rural patient population. Sashi Naidu, MD, director of research, discusses delivering next-generation sequencing testing to patients.
Novel Machine Learning Model May Detect Pulmonary Hypertension EarlierFebruary 24th 2023
Having a diagnostic model that leverages artificial intelligence could fill a gap in the pulmonary hypertension (PH) diagnostic pathway, as there are currently just 2 validated screening algorithms for PH.
Panel Addresses How Payers, Providers Can Optimally Use Real-World Evidence to Advance Cancer CareFebruary 23rd 2023
Utilizing real-world evidence that applies to the specific care needs of certain patient populations can promote timely decision-making among payers and providers on the use of effective cancer therapies available on the market, said panelists at the 2022 Patient-Centered Oncology Care® (PCOC) meeting.
Postdischarge Telemonitoring, Telephone Coaching May Benefit Certain Patients With Heart FailureFebruary 17th 2023
Patients with heart failure and high comorbidity burdens who received postdischarge noninvasive telemonitoring and nurse telephone coaching showed better survival outcomes than those who received standard care.
Eczema Self-management for Patients, Caregivers Benefits From Online AssistanceFebruary 11th 2023
This exploration of eczema self-management investigated the potential effectiveness of 2 online behavioral interventions, 1 each for young patients and their parents and/or caregivers.
Dr Michael Cohen Discusses Accessibility of Future Gene TherapiesFebruary 9th 2023
Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.
Angiogenesis Meeting to Highlight Latest in Technology, Translational Research, Clinical TrialsFebruary 8th 2023
The Angiogenesis, Exudation, and Degeneration 2023 meeting will be held virtually with a program focused on understanding and treating neovascular, exudative, and degenerative diseases of the eye.